Innovation Compounding

Kennesaw, United States Founded: 2007 • Age: 19 yrs Acquired By Revelation Pharma
Provider of drug compounding services
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors 1 Known backers
Products - Services tracked
Competitors 11 Brand Intelligence

About Innovation Compounding

Innovation Compounding is a company based in Kennesaw (United States) founded in 2007 was acquired by Revelation Pharma in January 2022. Innovation Compounding operates in a competitive market with competitors including Fagron, RareStone Group, Revelation Pharma, Pharmedium and Syntis, among others.

  • Headquarter Kennesaw, United States
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Healthcare Services & Infrastructure Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
  • Employee Count
    Not available
  • Acquired by
    Revelation Pharma

    (Jan 27, 2022)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Innovation Compounding

Premium access

Detailed funding history for Innovation Compounding

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investors in Innovation Compounding

Innovation Compounding has secured backing from 1 investor. Prominent investors backing the company include Revelation Pharma.

All
Investor Description Founded Year Domain Location
A network of compounding pharmacies is operated nationwide.
Locked Locked Locked
Premium access

Investor details for Innovation Compounding

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Innovation Compounding

Investments
Premium access

Investment portfolio details for Innovation Compounding

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Innovation Compounding

Premium access

Detailed financials for Innovation Compounding

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Innovation Compounding Comparisons

Innovation Compounding Primary company
Description
Provider of drug compounding services
Location
Kennesaw, United States
Founded Year
2007
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Innovation Compounding

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Innovation Compounding

Innovation Compounding operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Fagron, RareStone Group, Revelation Pharma, Pharmedium and Syntis, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Drug compounding services are provided by Fagron.
Locked Locked Locked
Provider of network and treatments to individuals and their families affected by rare diseases drugs
Locked Locked Locked
A network of compounding pharmacies is operated nationwide.
Locked Locked Locked
Drug compounding services are provided to healthcare facilities nationwide.
Locked Locked Locked
Drug compounding services are provided by Syntis in healthcare.
Locked Locked Locked
Pharmaceutical drugs are manufactured by Medac in Germany.
Premium access

Detailed competitors of Innovation Compounding

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Innovation Compounding

Premium access

Complete news archive for Innovation Compounding

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Innovation Compounding

Innovation Compounding was founded in 2007.

Innovation Compounding is headquartered in Kennesaw, United States. It is registered at Kennesaw, Georgia, United States.

Innovation Compounding was established in 2007 in Kennesaw, United States, within the pharmaceutical sector. Customized drug formulations are prepared through compounding processes to address specific patient requirements. Services encompass sterile and non-sterile compounding, adhering to regulatory standards. Operations are centered on healthcare providers and patients, with a focus on precision in medication preparation across the region.

Innovation Compounding's top competitors include Syntis, Ignota Labs and Fagron.

Innovation Compounding has 1 investor. Key investors include Revelation Pharma.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available